InvestorsHub Logo
Followers 5
Posts 1418
Boards Moderated 0
Alias Born 11/10/2015

Re: None

Monday, 08/31/2020 1:10:48 PM

Monday, August 31, 2020 1:10:48 PM

Post# of 58917
We have a linear dna covid19 vaccin competitor (although Touchlight foresees start of human trials not earlier than in Q2 2021)

touchlight-announces-development-of-a-vaccine-for-sars-cov-2

For those still questioning the viability of LinearX dna production platform: read and learn Touchlights platform emphasizes the same advantages as adnas does. Also Touchlight, although private, has seen a 500mln in investments over the years....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News